Addressing Hazards from Unscheduled Novel Psychoactive Substances as Research Chemicals: The Case of U-50488.
| Autor: | Amin ZM; Thomas J. Long School of Pharmacy & Health Sciences, University of the Pacific., Rambaran KA; Department of Clinical Sciences, Keck Graduate Institute., Fleming SW; Reference Health Laboratories, Gulfstream Diagnostics., Cho K; Reference Health Laboratories, Gulfstream Diagnostics., Chacko L; Reference Health Laboratories, Gulfstream Diagnostics., Alzghari SK; Gulfstream Genomics, Gulfstream Diagnostics. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2017 Dec 06; Vol. 9 (12), pp. e1914. Date of Electronic Publication: 2017 Dec 06. |
| DOI: | 10.7759/cureus.1914 |
| Abstrakt: | Increased experimentation with easily accessible synthetic opioids is posing a hazard to the public. We discuss one such synthetic opioid, U-50488. Much is unknown about U-50488; however, due to its structural similarity to U-47700, there is possible risk associated with its use. Curtailing the use of synthetic opioids such as U-50488 will require a concerted effort targeting multiple problems. Competing Interests: The authors have declared financial relationships, which are detailed in the next section. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|